The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment - Suggested disease management guidelines

被引:97
作者
Fennerty, MB
Castell, D
Fendrick, AM
Halpern, M
Johnson, D
Kahrilas, PJ
Lieberman, D
Richter, JE
Sampliner, RE
机构
[1] UNIV PENN, GRAD HOSP, DEPT MED, PHILADELPHIA, PA 19104 USA
[2] UNIV MICHIGAN, DEPT MED, ANN ARBOR, MI 48109 USA
[3] BATELLE INST, DEPT MED, ARLINGTON, VA USA
[4] EASTERN VIRGINIA MED SCH, DEPT MED, NORFOLK, VA 23501 USA
[5] NORTHWESTERN UNIV, DEPT MED, CHICAGO, IL 60611 USA
[6] CLEVELAND CLIN FDN, DEPT MED, CLEVELAND, OH 44195 USA
[7] ARIZONA HLTH SCI CTR, DEPT MED, TULSA, OK USA
关键词
D O I
10.1001/archinte.156.5.477
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A group of experts from gastroenterology, internal medicine, health economics, medical outcomes, and managed care met in San Francisco, Calif, on September 27, 1994, in an effort to develop clinically and economically effective disease management guidelines to assist physicians in their treatment of gastroesophageal reflux disease in a managed care environment. This article represents a consensus opinion based on the evidence and expert interpretation at the time of that meeting.
引用
收藏
页码:477 / 484
页数:8
相关论文
共 59 条
[1]   OMEPRAZOLE IN THE TREATMENT OF EROSIVE ESOPHAGITIS REFRACTORY TO HIGH-DOSE CIMETIDINE AND RANITIDINE [J].
BARDHAN, KD ;
MORRIS, P ;
THOMPSON, M ;
DHANDE, DS ;
HINCHLIFFE, RFC ;
JONES, RB ;
DALY, MJ ;
CARROLL, NJH .
GUT, 1990, 31 (07) :745-749
[2]   COMPARISON OF OMEPRAZOLE AND CIMETIDINE IN REFLUX ESOPHAGITIS - SYMPTOMATIC, ENDOSCOPIC, AND HISTOLOGICAL EVALUATIONS [J].
BATE, CM ;
KEELING, PWN ;
OMORAIN, C ;
WILKINSON, SP ;
FOSTER, DN ;
MOUNTFORD, RA ;
TEMPERLEY, JM ;
HARVEY, RF ;
THOMPSON, DG ;
DAVIS, M ;
FORGACS, IC ;
BASSETT, KS ;
RICHARDSON, PDI .
GUT, 1990, 31 (09) :968-972
[3]  
BRAND DL, 1979, GASTROENTEROLOGY, V76, P1393
[4]   PREVALENCE OF COLUMNAR-LINED (BARRETT) ESOPHAGUS - COMPARISON OF POPULATION-BASED CLINICAL AND AUTOPSY FINDINGS [J].
CAMERON, AJ ;
ZINSMEISTER, AR ;
BALLARD, DJ ;
CARNEY, JA .
GASTROENTEROLOGY, 1990, 99 (04) :918-922
[5]   ESOPHAGITIS IS AS IMPORTANT AS ESOPHAGEAL STRICTURE DIAMETER IN DETERMINING DYSPHAGIA [J].
DAKKAK, M ;
HOARE, RC ;
MASLIN, SC ;
BENNETT, JR .
GUT, 1993, 34 (02) :152-155
[6]   OMEPRAZOLE V RANITIDINE FOR PREVENTION OF RELAPSE IN REFLUX ESOPHAGITIS - A CONTROLLED DOUBLE-BLIND TRIAL OF THEIR EFFICACY AND SAFETY [J].
DENT, J ;
YEOMANS, ND ;
MACKINNON, M ;
REED, W ;
NARIELVALA, FM ;
HETZEL, DJ ;
SOLCIA, E ;
SHEARMAN, DJC .
GUT, 1994, 35 (05) :590-598
[7]   MECHANISM OF GASTROESOPHAGEAL REFLUX IN RECUMBENT ASYMPTOMATIC HUMAN-SUBJECTS [J].
DENT, J ;
DODDS, WJ ;
FRIEDMAN, RH ;
SEKIGUCHI, T ;
HOGAN, WJ ;
ARNDORFER, RC ;
PETRIE, DJ .
JOURNAL OF CLINICAL INVESTIGATION, 1980, 65 (02) :256-267
[9]   QUALITY-OF-LIFE IN PATIENTS WITH UPPER GASTROINTESTINAL SYMPTOMS - AN IMPROVED EVALUATION OF TREATMENT REGIMENS [J].
DIMENAS, E ;
GLISE, H ;
HALLERBACK, B ;
HERNQVIST, H ;
SVEDLUND, J ;
WIKLUND, I .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1993, 28 (08) :681-687
[10]  
*GALL ORG INC, 1988, HEARTB ACR AM